Innovative Melphalan Oral Formulation to Improve Bioavailability

来源 :2015年中国药物制剂大会、中国药学会药剂专业委员会2015年学术年会暨国际控释协会中国分会2015年学术年会 | 被引量 : 0次 | 上传用户:xiao040223
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Melphalan is a chemotherapy agent that has been used to treat multiple myeloma, ovarian cancer, Al amyloidosis, and occasionally malignant melanoma.Commercial Melphalan products include Alkeran (Melphalan Hydrochloride) for Injection 50 mg and Alkeran (Melphalan) Tablets 2 mg.
其他文献
会议
  Paclitaxel (PTX) is an antitumor drug which has been widely adopted in clinical treatment of cancer for years.However, it is characterized significant disad
会议
  Lack of desirable release profile and rational drug combination are the major obstacles in successfully developing nano-sized codelivery system to reverse d
会议
  Objective:Recombinant Human growth hormone (rhGH) has been used for treatment of pediatric short stature caused by growth hormone deficiency, Turner's syndr
会议
会议
  Sexual reproduction of scleractinian corals is among the most important means of establishing coral populations.However,so far,very little is known about th
会议
会议
会议
会议